Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ANTITHROMBIN III NF DIN 02237810

Status: Marketed
Holder: TAKEDA CANADA INC
Molecule: ANTITHROMBIN III (HUMAN)

Health Canada record

Active ingredient(s)ANTITHROMBIN III (HUMAN) 1100 UNIT
Dosage formPowder For Solution; Kit
RouteIntravenous
ScheduleSCHEDULE D
ClassHuman
ATCB01AB02 ANTITHROMBIN
Original market date05-Jul-1999
Current status date28-Jan-2022
SourceHealth Canada DPD

Establishment licence of the holder

Takeda Canada Inc. — licence 101769, currently licensed, last inspection rating C (2026-02-24).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ANTITHROMBIN III (HUMAN)

DINProductCompanyFormStrengthStatus
02237811ANTITHROMBIN III NFTAKEDA CANADA INCKit; Powder For SolutionANTITHROMBIN III (HUMAN) 550 UNITMarketed
02189135THROMBATE IIIGRIFOLS THERAPEUTICS LLCPowder For SolutionANTITHROMBIN III (HUMAN) 500 UNITApproved
02237812ANTITHROMBIN III IMMUNOBAXTER AGPowder For SolutionANTITHROMBIN III (HUMAN) 1650 UNIT; WATER 30 MLCancelled Post Market
02189143THROMBATE IIIGRIFOLS THERAPEUTICS LLCPowder For SolutionANTITHROMBIN III (HUMAN) 1000 UNITCancelled Post Market
02020572THROMBATE III PWS IV 1000IU/VIALMILES INC. - PHARMACEUTICAL DIVISIONPowder For SolutionANTITHROMBIN III (HUMAN) 1000 UNITCancelled Post Market
02020580THROMBATE III PWS IV 500IU/VIALMILES INC. - PHARMACEUTICAL DIVISIONPowder For SolutionANTITHROMBIN III (HUMAN) 500 UNITCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
210822018-07-13New Drug Submission (NDS)MERGER - BUYOUT
168312015-04-21New Drug Submission (NDS)MANUFACTURER NAME CHANGE
15611999-11-08New Drug Submission (NDS)
26901998-04-15New Drug Submission (NDS)
Request a quote for ANTITHROMBIN III NF

How to read a Canadian DIN record